The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Fuhrman grade and concomitant bisphosphonates as additional prognostic factors in metastatic renal cell carcinoma with bone metastases treated with sunitinib.
Benoit L. M. Beuselinck
No relevant relationships to disclose
Jacques Medioni
No relevant relationships to disclose
Pascal Wolter
No relevant relationships to disclose
Aurore Blesius
No relevant relationships to disclose
Alexandra Karadimou
No relevant relationships to disclose
Patrick Schöffski
No relevant relationships to disclose
Bernard J. Escudier
No relevant relationships to disclose
Jessica Zucman-Rossi
No relevant relationships to disclose
Robert Paridaens
No relevant relationships to disclose
Stephane Oudard
No relevant relationships to disclose